Sierra Oncology SRRA
$ 54.89
-0.05%
Quarterly report 2022-Q1
added 12-16-2023
Country |
Canada |
IPO year |
2015 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Nicholas Glover |
Employees in the company |
71 |
Shares |
13.3 M |
Market Cap[1] |
$ 1.34 B |
EBITDA (LTM) |
$ -96.7 M |
P/E (LTM) |
-8.06 |
P/S (LTM) |
4467.93 |
EPS (LTM) |
-6.81 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.